MentionFox
Home › Executive changes › GeneDx Holdings Corp.
Leadership changes · WGS · SEC Form 8-K, Item 5.02

Leadership changes at GeneDx Holdings Corp. (2026)

Before you join, sell to or invest in GeneDx Holdings Corp.

MentionFox check on GeneDx Holdings Corp.: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/genedx-holdings

Check GeneDx Holdings Corp. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about GeneDx Holdings Corp.?

Who joined and who left GeneDx Holdings Corp. (WGS)? 1 appointment reported on 2026-06-16, each cited to the company's own filing.

Mark Gardner was named President of GeneDx Holdings Corp., effective June 15, 2026. As of November 15, 2026, GeneDx Holdings Corp. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 16, 2026, naming 1 appointment (Form 8-K, June 16, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Summit Partners Public Asset Management, LLC also filed stake reports on 1 other company ↓

Sell to companies like GeneDx Holdings Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
In (appointed)1
Latest filing2026-06-16

GeneDx Holdings Corp. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-16. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as GeneDx Holdings Corp. files it.

Also on the record for GeneDx Holdings Corp.

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC6.42% of the class5%+ stakesSource
November 6, 2026Stake report, Schedule 13G, by WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC5.2% of the class5%+ stakesSource
August 11, 2026Stake report, Schedule 13G, by THE GOLDMAN SACHS GROUP, INC.5.8% of the class5%+ stakesSource
August 7, 2026Stake report, Schedule 13G/A, by ARK Investment Management LLC5.33% of the class5%+ stakesSource
July 28, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.5% of the class5%+ stakesSource
May 22, 2026Stake report, Schedule 13D/A, by CMLS Holdings LLC17.9% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13D/A, by CMLS HOLDINGS LLC17.9% of the class5%+ stakesSource
May 11, 2026Stake report, Schedule 13D/A, by CMLS HOLDINGS LLC16.7% of the class5%+ stakesSource
November 12, 2025Stake report, Schedule 13G/A, by WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC4.3% of the class5%+ stakesSource
August 26, 2025Stake report, Schedule 13D/A, by CMLS Holdings LLC12.5% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Summit Partners Public Asset Management, LLC3.04% of the class5%+ stakesSource
August 6, 2025Stake report, Schedule 13G/A, by FMR LLC0.6% of the class5%+ stakesSource

Selling to them or working with them? See who runs GeneDx Holdings Corp. now and the warning signs.

Free to see. No signup.

Keep reading

More on GeneDx Holdings Corp. and the records around it.

GeneDx Holdings Corp. elsewhere on the record

Companies that share a holder

Want the whole picture on GeneDx Holdings Corp.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on GeneDx Holdings Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on GeneDx Holdings Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 13 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-06-16InPresident2026-06-158-K, 2026-06-16

Who leads GeneDx Holdings Corp., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to GeneDx Holdings Corp.?

New leaders reset buying decisions — get the Full Report on GeneDx Holdings Corp.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch GeneDx Holdings Corp.

Hiring for a seat like this?

Find people with the same kind of experience as the President at GeneDx Holdings Corp., with the record behind each one.

Find candidates like President at GeneDx Holdings Corp.

Every change, in the filing's words

Filed 2026-06-16 · 8-K

Appointed: Mark Gardner, President, effective 2026-06-15

On June 16, 2026, GeneDx Holdings Corp. (the "Company") announced the appointment of Mark Gardner, age 60, in the role of President, which was effective on June 15, 2026.

Also stated in this filing

  • As President, Mr. Gardner will oversee the Company's lab and commercial operations.
  • Mr. Gardner will report to Katherine Stueland, Chief Executive Officer of the Company, and will serve on the Company's executive leadership team.
  • Prior to joining the Company, Mr. Gardner served as Senior Vice President of Molecular Genomics and Oncology at Quest Diagnostics Incorporated, from September 2022 to June 2026.
  • Mr. Gardner also held executive leadership roles at prominent diagnostic and life sciences companies, including at Corza Medical Inc., where he was Executive Partner, Senior Vice President and General Manager of European Commercial Operations and Biosurgery Products from June 2019 to October 2022, at OmniSeq Corporation, where he was Chief Executive Officer, and at Thermo Fisher Scientific Inc., where he held Vice President and General Manager positions.
  • Mr. Gardner holds a B.S. in History from the United States Naval Academy, an M.A. in National Security Studies from Georgetown University, and an M.B.A. from The Wharton School of the University of Pennsylvania.
  • The employment agreement provides for an initial term of three years and automatically renews for successive one-year terms unless earlier terminated.

Tools for this story

Each opens in a new tab, filled in for GeneDx Holdings Corp.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/genedx-holdings
Last updated 2026-11-15
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
GeneDx Holdings Corp. names Mark Gardner President (2026). MentionFox, 2026-11-15. https://mentionfox.com/executive-changes/genedx-holdings